BrainsWay is transitioning from a device manufacturer to a capital-light ecosystem provider for inte

Brainsway Ltd. Sponsored ADR (NASDAQ: BWAY - Get Free Report)'s share price hit a new 52-week high d

Brainsway (BWAY) could be a great choice for investors looking to make a profit from fundamentally s

Terumo, QuidelOrtho, Lumexa Imaging and BrainsWay are tackling industry headwinds through innovation

BrainsWay continues to actively evaluate similar investments in leading North American mental health

BTIG analyst Sam Eiber initiates coverage on BrainsWay (NASDAQ:BWAY) with a Buy rating and announ

BrainsWay Ltd. (NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global le

Investment further supports BrainsWay's strategy of partnering with growth-oriented mental health pr

BWAY, HTLD and NCNO made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on July 14th, 202

HTLD, MEOH, NCNO, JD and BWAY have been added to the Zacks Rank #1 (Strong Buy) List on July 14th, 2

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates BrainsWay (NASDAQ:BWAY) with a Buy

BrainsWay Ltd. (NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global le

Nearly half of individuals diagnosed with PTSD also meet criteria for major depressive disorder (MDD

BrainsWay Ltd. (NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global le

BURLINGTON, Mass. and JERUSALEM, June 22, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BW

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates BrainsWay (NASDAQ:BWAY) with a Buy

BrainsWay Ltd., a global leader in advanced noninvasive neurostimulation treatments for mental healt

Preliminary Data Analysis Reveals Over 80% Remission Rate One Year after Accelerated Deep TMS Treatm

HC Wainwright & Co. analyst Raghuram Selvaraju maintains BrainsWay (NASDAQ:BWAY) with a Buy a

BrainsWay Ltd. (NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global le

Investment in provider servicing clinics in Illinois is latest in series of similar transactions by

BrainsWay Ltd. (BWAY) Q1 2026 Earnings Call Transcript

Brainsway NASDAQ: BWAY reported a strong start to 2026, with first-quarter revenue rising 35% year o

BrainsWay (NASDAQ:BWAY) affirms FY2026 sales outlook from $66.000 million-$68.000 million to $66.000

BrainsWay (NASDAQ:BWAY) reported quarterly earnings of $0.06 per share which beat the analyst consen

R evenue grew approximately   35 % y ear- o ver- y ear to   $1 5 .5 million  for Q1 2026

Here is how Brainsway Ltd. Sponsored ADR (BWAY) and CG Oncology, Inc. (CGON) have performed compared

Brainsway (BWAY) made it through our "Recent Price Strength" screen and could be a great choice for

BURLINGTON, Mass. and JERUSALEM, April 29, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: B

The Zacks Medical - Products industry faces macro headwinds, keeping growth under pressure in 2026,

BrainsWay continues to deliver strong growth and margin improvement, supported by investments in TMS

BrainsWay Ltd. (NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global le

Dow futures down 0.2%. Hesai Group -ADR shares drop 6.6% after reporting lower quarterly earnings an

Dow futures down 0.2%. Hesai Group -ADR shares drop 6.6% after reporting lower quarterly earnings an

BrainsWay Ltd. (NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global le

Top analysts change outlook on top names. HC Wainwright cut BWAY price target, Mizuho raised PENN ta

HC Wainwright & Co. analyst Raghuram Selvaraju maintains BrainsWay (NASDAQ:BWAY) with a Buy a

BrainsWay Ltd.

BrainsWay (NASDAQ:BWAY) reported quarterly earnings of $0.04 per share which met the analyst consens

Health care sector has oversold stocks, RSI momentum indicator can help traders predict short term p

BrainsWay Ltd. (NASDAQ & TASE: BWAY) unveiled new clinical data showing a significantly faster,

Under the terms of the agreement, BrainsWay will invest $1.0 million initially, with potential for a

BrainsWay Ltd. (NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global le